Predictors of the outcome of immune tolerance induction in patients with haemophilia A and inhibitors: The Brazilian Immune Tolerance (BrazIT) Study protocol.
The development of inhibitors is the main complication of haemophilia A (HA) treatment. Immune tolerance induction (ITI) is the treatment of choice for inhibitor eradication. We describe the methodology of the Brazilian Immune Tolerance Induction (BrazIT) Study, aimed to identify clinical, genetic,...
Guardado en:
Autores principales: | Ricardo Mesquita Camelo, Daniel Gonçalves Chaves, Luciana Werneck Zuccherato, Suely Meireles Rezende, BrazIT Study Team |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d3528379870248beac4ad16a9ec177c2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Induction of Immune Tolerance in Islet Transplantation Using Apoptotic Donor Leukocytes
por: Naoya Sato, et al.
Publicado: (2021) -
Immune Tolerance in the Oral Mucosa
por: Hector F. Pelaez-Prestel, et al.
Publicado: (2021) -
Induction of antigen-specific immune tolerance using biodegradable nanoparticles containing antigen and dexamethasone
por: Kim SH, et al.
Publicado: (2019) - Haemophilia
-
HAEMOPHILIA AND NURSING CARE
por: Marcela Ganzella
Publicado: (2021)